Event Date/Time: Jan 19, 2011 End Date/Time: Jan 20, 2011
Report as Spam


Are you a pharmaceutical leader looking for strategic partners to boost your pipeline and bring new, innovative products to market? Or are you a biotech firm seeking funding to drive your research to drug delivery? If so, then block the 19th-20th January 2011 in your diary since the annual BioBusiness Forum returns to London, providing you with the ideal platform to meet potential partners and form new, strategic alliances.

With businesses under more pressure to innovate than ever before, regardless of the cost-cutting climate, now is the time to find ways to enhance the product pipeline and drive new drugs to market and emerge from the economic crisis with the competitive edge. By joining BioBusiness 2011, you will have the opportunity to network with the leading big and mid-tier pharmaceutical companies, as well as the most innovative biotech firms across the globe. Furthermore, given the intimate nature of this event, rather than spend two days searching for the right person amongst the crowd, you will have the chance to spend quality time discussing the key issues with all the key people you wish to meet.

Leading speakers confirmed to be participating in BioBusiness 2011 include:

Nils Debus, Senior Director, Global Business Development and Licensing, Global Transactions,Bayer Schering Pharma AG
Rob Grundy, Research Alliances Director, Almac Discovery
Ulrich Dauer, CEO, 4SC
Roger Hill, Executive Director, Global Licensing and Business Development,Boehringer Ingelheim
Magnus Bjorsne, Global Business Development Director,AstraZeneca
Christian Kanstrup, Corporate Vice President, Corporate Strategy and Business Development, Novo Nordisk
Dr. Michael Capaldi, Director of Commercialisation, Edinburgh BioQuarter, Edinburgh University
Dr. Howard Marriage, CEO,NeurocentRx
Dr. Ehud Hauben, Business Development, LeidenUniversity Medical Center
Chris Piggott, Chief Business Officer,Biotie
Hans Loibner, CEO, Apeiron Biologics
Biobusiness 2011: Designed To Bring Big Pharma And Biotech Together

BioBusiness 2011 will provide with you two days of networking, case studies, roundtable discussions and investment challenges, ensuring you make the most of your experience at the forum. Features for 2011 include:

Pre-arranged one-to-meetings: set up onsite meetings prior to the event, ensuring you have total control over the key personnel you choose to meet
Investment challenge: biotechs pitch their projects to the pharma community live on stage, offering a vital insight into the new ideas from the biotech world
Peer-to-peer roundtable discussions: immerse yourself in the debate during interactive discussions, all within a bespoke networking environment
In-depth conference agenda: hear the latest case studies from strategic alliances all over Europe and understand expectations and results
With the world’s leading minds in attendance, as well as one-to-one meetings, roundtable discussions and investment challenges, BioBusiness 2011 will be the ideal opportunity for licensing, alliance management and business development strategists to come together and develop their next wave of partners to drive profitability through innovation

For more details and a rundown on who will be attending or to find out if your company is elegible for any discounts, contact us on:
Contact Us By Phone
+44(0)20 7368 9465
E-mail Us